Enter assignee name

CIPO Patents = 4

EPO Patents = 4

Trademarks = 4

Forward Citations = 43

Loading Chart...

3 inventors (with patents filed for the assignee):

Luigi Moro (10 out of 32 patents)

Mauro Ajani (10 out of 44 patents)

Luigi Maria Longo (4 out of 16 patents)

4. Michael Albeck (36 patents)

5. Benjamin Sredni (32 patents)

14 patents: Sort by Forward Citations

1. 12337002 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2025-06-24),

2. 11938141 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2024-03-26),

3. 11883415 - High concentration formulation (2024-01-30),

4. 11213531 - High concentration formulation (2022-01-04),

5. 11207332 - Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2021-12-28),

6. 10980819 - High concentration formulation (2021-04-20),

7. 10716796 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2020-07-21),

8. 10603327 - High concentration formulation (2020-03-31),

9. 10166245 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2019-01-01),

10. 10159682 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2018-12-25),

11. 9895379 - 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents (2018-02-20),

12. 9486458 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2016-11-08),

13. 9433628 - Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2016-09-06),

14. 9211295 - 17 alpha, 21-dihydroxypregnene esters as antiandrogenic agents (2015-12-15),

Cassiopea is a pharmaceutical company focused on developing and commercializing innovative medical solutions. With a commitment to delivering improved treatments, Cassiopea specializes in dermatology and women's health. The company believes in advancing patient care by developing safe, effective, and well-tolerated therapies. Through its research and development efforts, Cassiopea strives to enhance the quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.